Developing novel diagnostics compact devices to enable hospitals a better stratification of sepsis in patients.
Viva in Vitro has raised €2.5M across 2 funding rounds from 2 investors, most recently a round in Jul 2024. Based in Murcia, Spain; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2024-07-09 | Other | €1.3M | Institute for the Promotion of the Region of Murcia | View deal → |
| 2023-02-24 | Other | €1.2M | Private Investors | View deal → |
